You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPI 3-5

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +68 more
Mar 15, 2021

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)

Not yet recruiting
  • Gorlin Syndrome
  • Patidegib Topical Gel
  • Vehicle Gel
  • (no location specified)
Sep 15, 2023

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

Female Infertility Trial in Cairo (Extended culture for Group 2: (day 3-5 group))

Active, not recruiting
  • Female Infertility
  • Extended culture for Group 2: (day 3-5 group)
  • Cairo, Al-Azhar University, Al-Darrasah, Egypt
    International Islamic Center for Population Studies and Research
May 12, 2023

Healthy Trial in Lenexa (IPI-145, Midazolam)

Completed
  • Healthy
  • Lenexa, Kansas
    PRA International
Mar 15, 2021

Healthy Trial in Lenexa (IPI-145, Rifampin)

Completed
  • Healthy
  • Lenexa, Kansas
    PRA International, Inc
Mar 15, 2021

Diabetic Foot Infection Trial (5% Nu-3 gel, 10% Nu-3 gel, Placebo)

Not yet recruiting
  • Diabetic Foot Infection
  • 5% Nu-3 gel
  • +2 more
  • (no location specified)
Aug 27, 2023

Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)

Completed
  • Diffuse B-Cell Lymphoma
  • Avadomide (CC-122)
  • +4 more
  • Washington, District of Columbia
  • +14 more
Apr 28, 2021

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +7 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
Jul 20, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Duarte, California
  • +2 more
Oct 7, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Avoidance of Futile Excisions Through Skin Tele-triage

Enrolling by invitation
  • Melanoma (Skin)
  • Telemedicine
  • Single Assessor Teledermatological triage (TDT)
  • +3 more
  • Brønshøj, Copenhagen, Denmark
    Gustav Gede Nervil
Aug 1, 2023

Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Nivolumab
  • Ipilimumab
  • Saint Louis, Missouri
  • +11 more
Dec 15, 2022

CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))

Not yet recruiting
  • CIN 2/3
  • HIV Infections
  • Intravaginal 5-Fluorouracil (5-FU)
  • Lilongwe, Malawi
    UNC Project, Kamuzu Central Hospital
Jan 17, 2023

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Jun 26, 2023

Asthma Trial in Germany, United Kingdom (IPI-145, a PI3K Inhibitor, Placebo to match IPI-145)

Completed
  • Asthma
  • IPI-145, a PI3K Inhibitor
  • Placebo to match IPI-145
  • Berlin, Germany
  • +3 more
Mar 15, 2021

Chemo-induced Nausea and Vomiting Trial in Chengdu (5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 27, 2023

Recurrent Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Nodal Marginal Zone Lymphoma Trial (Acalabrutinib,

Withdrawn
  • Recurrent Follicular Lymphoma
  • +8 more
  • (no location specified)
Jun 2, 2022

Neuronal Ceroid Lipofuscinosis CLN5 Trial in Rochester (NGN-101)

Recruiting
  • Neuronal Ceroid Lipofuscinosis CLN5
  • NGN-101
  • Rochester, New York
  • +1 more
Jan 19, 2023

Breast Cancer, Chemo-Related Cognitive Impairment Trial in Miami (Individualized Piano Keyboard Instruction)

Completed
  • Breast Cancer
  • Chemotherapy-Related Cognitive Impairment
  • Individualized Piano Keyboard Instruction
  • Miami, Florida
    University of Miami
Jun 9, 2023

Advanced Solid Tumors (Part A/B/C/D), NSCLC (Part E), Melanoma (Part E) Trial in United States (IPI-549 (eganelisib), Nivolumab)

Active, not recruiting
  • Advanced Solid Tumors (Part A/B/C/D)
  • +7 more
  • San Diego, California
  • +10 more
Apr 1, 2022

Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)

Recruiting
  • Healthy
  • 5-MTHF glucosamine salt
  • +2 more
  • Saint-Herblain, France
    Biofortis
Jan 31, 2023